Dr Brown is the developer of the aProximateTM assay for measuring kidney transporter and nephrotoxicity licensed exclusively to Newcells Biotech. The World Preclinical Congress is a key networking event focusing on…
Read update 13th June, 2018Dr Chichagova will be talking about Retinitis Pigmentosa, one of the most common forms of inherited blindness affecting over 1 million people worldwide.With no effective treatment available for Retinitis…
Read update 23rd May, 2018Using statistical modelling, Dr Chichagova was able to improve the differentiation outcome of human induced pluripotent stem cells to retinal organoids, which were subsequently successfully tested with a toxicologically relevant test compound. As…
Read update 13th April, 2018Hilton Gateshead – 16th-18th April http://www.thebts.org/bts-annual-congress-2018/ The Newcells Biotech team will be attending the British Toxicological Society Annual Congress 2018 that is taking place in Gateshead on 16th-18th April. Newcells Biotech staff…
Read update 13th December, 2017Current cell assays for in vitro screening are based on genetically modified cell lines which are crude models of human biology. Typically, these assays have used immortalised cell lines derived from…
Read update 13th December, 2017These hiPSCs under the right culture conditions will differentiate into a wide range of cell types. This technology enables the supply of unlimited quantities of tissues from healthy individuals…
Read update